spacer
home > ebr > winter 2002 > overview of the biotechnology industry in finland
PUBLICATIONS
European Biopharmaceutical Review

Overview of the Biotechnology Industry in Finland

Finland's knowledge-based growth strategy provides strong support for research and development, with investments in R&D having risen steadily since the early 1980s. In this respect, the most important recent event was the decision taken by the Government in 1996 to allocate funds from the privatisation of state-owned companies to fund science and technology. The goal was to increase the national R&D input to 2.9 per cent of GDP by 1999. Owing to rapidly increasing investment by the private sector, this level was achieved a year ahead of schedule. Today the figure, which is made up of public funding and the input from industry, has risen to 3.6 per cent. This puts Finland second in the world for R&D spending per capita. Of the total R&D investment, 29 per cent is funded by Government and 71 per cent by the private sector.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Sirkka Aura, CEO of Invest in Finland Sirkka Aura is Chief Executive Officer of Invest in Finland. Her particular expertise lies in the banking and financial sectors and is complemented by industry knowledge from a wide range of fields.
Prior to joining the IFB, Sirkka spent 12 years with Leonia Bank Oy in various posts including two years as Vice-President of their New York branch and several years as Manager of the bank's foreign corporate customers. She has an MSc from the Helsinki School of Economics and Business Administration.

spacer
Sirkka Aura
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaisala Introduces CAB100 Industrial Cabinet for Cleanrooms

Vaisala, a global leader in weather, environmental, and industrial measurements, launches its newest offering for centralized environmental monitoring in cleanrooms: The CAB100 integrates Vaisala’s world-class instruments for monitoring parameters into a simple, pre-configured enclosure.
More info >>

White Papers

Another Successful Visit Against the Odds

Medical Research Network (MRN) Limited

Our dedicated team of nurses, couriers and project managers deliver, come rain or shine. Making sure a Clinical Trial visit can go ahead in the home can be a complex process, and last month bad weather nearly stopped play on an important Home Trial Support visit. Thanks to the commitment and dedication from the entire team it went ahead against the odds.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement